Evidence map›Paper›PMID 31430451›Full record

ArticleDevelopmental cell2019

Temporal Ordering in Endocytic Clathrin-Coated Vesicle Formation via AP2 Phosphorylation.

Antoni G Wrobel, Zuzana Kadlecova, Jan Kamenicky, Ji-Chun Yang, Torsten Herrmann, Bernard T Kelly, Airlie J McCoy, Philip R Evans, Stephen Martin, Stefan Müller and 5 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Developmental cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. eLife · 2024
    Article
  13. Article
  14. Cells · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Antoni G WrobelCIMR, WT/MRC Building, Hills Road, Cambridge CB2 0QQ, UK.
Zuzana KadlecovaCIMR, WT/MRC Building, Hills Road, Cambridge CB2 0QQ, UK. Electronic address: zk241@cam.ac.uk.
Jan KamenickyCzech Academy of Sciences, Institute of Information Theory and Automation, Pod Vodarenskou vezi 4, 182 08 Prague 8, Czech Republic.
Ji-Chun YangMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Torsten HerrmannUniversity of Grenoble Alpes, CNRS, CEA, IBS, 38000 Grenoble, France.
Bernard T KellyCIMR, WT/MRC Building, Hills Road, Cambridge CB2 0QQ, UK.
Airlie J McCoyCIMR, WT/MRC Building, Hills Road, Cambridge CB2 0QQ, UK.
Philip R EvansMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Stephen MartinThe Francis Crick Institute, 1 Midland Road, London NW1 1ST, UK.
Stefan MüllerCenter for Molecular Medicine (CMMC), University of Cologne, Robert-Koch-Straße 21, 50931 Cologne, Germany.
Susanne SalomonInstitute for Biochemistry I, Medical Faulty, University of Cologne, Joseph-Stelzmann-Straße 52, 50931 Cologne, Germany.
Filip SroubekCzech Academy of Sciences, Institute of Information Theory and Automation, Pod Vodarenskou vezi 4, 182 08 Prague 8, Czech Republic.
David NeuhausMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Stefan HöningInstitute for Biochemistry I, Medical Faulty, University of Cologne, Joseph-Stelzmann-Straße 52, 50931 Cologne, Germany. Electronic address: shoening@uni-koeln.de.
David J OwenCIMR, WT/MRC Building, Hills Road, Cambridge CB2 0QQ, UK.
MRC Laboratory of Molecular Biology · GBUniversity of Cologne · DECzech Academy of Sciences, Institute of Information Theory and Automation · CZCentre National de la Recherche Scientifique · FRThe Francis Crick Institute · GB

Funding

Medical Research Council MC_U105178845Medical Research Council MC_U105178934Wellcome Trust 090909/Z/09/ZWellcome Trust 097040/Z/11/ZWellcome Trust 207455/Z/17/Z
6 · The paper itself

Abstract

Clathrin-mediated endocytosis (CME) is key to maintaining the transmembrane protein composition of cells' limiting membranes. During mammalian CME, a reversible phosphorylation event occurs on Thr156 of the μ2 subunit of the main endocytic clathrin adaptor, AP2. We show that this phosphorylation event starts during clathrin-coated pit (CCP) initiation and increases throughout CCP lifetime. μ2Thr156 phosphorylation favors a new, cargo-bound conformation of AP2 and simultaneously creates a binding platform for the endocytic NECAP proteins but without significantly altering AP2's cargo affinity in vitro. We describe the structural bases of both. NECAP arrival at CCPs parallels that of clathrin and increases with μ2Thr156 phosphorylation. In turn, NECAP recruits drivers of late stages of CCP formation, including SNX9, via a site distinct from where NECAP binds AP2. Disruption of the different modules of this phosphorylation-based temporal regulatory system results in CCP maturation being delayed and/or stalled, hence impairing global rates of CME.

Indexed as

Adaptor Protein Complex 2Adaptor Protein Complex alpha SubunitsClathrinClathrin-Coated VesiclesCoated Pits, Cell-MembraneEndocytosisHumansPhosphorylationProtein BindingSorting NexinsAdaptor Protein Complex 2Adaptor Protein Complex alpha SubunitsClathrinNECAP1 protein, humanSNX9 protein, humanSorting NexinsAAK1AP2 endocytic adaptorclathrin-mediated endocytosiscrystallographyNECAPNMRNumb-associated kinases (NAK)regulation by phosphorylationSNX9TIRF

Identifiers

PMID31430451
PMCPMC6706699
OpenAlexW2969609011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.